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After the early wavering steps tracing back to at least the 1960’s
(Cone, 1974; Binggeli and Cameron, 1980), the study of ion trans-
port in cell proliferation and neoplasia is on its way to become
a mature research field (Arcangeli et al., 2009). Wide evidence
is now available about the regulatory roles exerted by ion chan-
nels and transporters on the cell cycle phases (Becchetti, 2011)
and other aspects of cell physiology that shape the multistep neo-
plastic progression, such as resistance to apoptosis (Lehen’kyi
et al., 2011), cell invasiveness (Becchetti and Arcangeli, 2010), and
angiogenesis (Fiorio Pla et al., 2012). Ion transport is implicated
in these cell functions in many ways, from the classic mechanisms
relating membrane potential (Vm) to Ca2+ homeostasis, to the
control of pH, cell volume, growth factor release, interaction with
the extracellular matrix, and so forth. Some of these actions prob-
ably occur through non-conductivemechanisms, such as intrinsic
enzyme activity or conformational coupling with other mem-
brane proteins (e.g., Arcangeli and Becchetti, 2006; Hegle et al.,
2006). A major function of ion channels is to mediate the cell
interaction with its environment. In the case of cancer cells, the
interaction with the tumor milieu’ has relevant implications for
therapy (Arcangeli, 2011).
The Research Topic Issue on Ion Transport in Cell Cycle and
Cancer addresses classic issues in the field as well as it points to
novel perspectives. One example of the latter is the role of Ca2+ in
autophagy (Rizzuto et al., 2012), which has not received as much
attention as Ca2+ signaling in the cell cycle machinery and apop-
tosis (Roderick and Cook, 2008; Munaron, 2012). As discussed
by Kondratskyi et al. (2013), modulating autophagy has a great
potential in cancer diagnosis and treatment. The review discusses
the related Ca2+-dependent mechanisms and their meaning in
the context of cancer progression and therapy. The role of Ca2+ in
autophagy is related to the increasing recognition of the multiple
functions of intracellular ion channels, which regulate ion trans-
port across the membranes of cellular organelles. Leanza et al.
(2013) provide an updated overview of the role of ion channels
in mitochondria, endoplasmic reticulum, nucleus, endosomes,
and lysosomes, with special attention to the implications for the
biology of cancer.
A general picture of the role of Vm in cell proliferation and dif-
ferentiation is provided by Yang and Brackenbury (2013), with a
special focus on voltage-gated channels. The paper reviews what
is known about the Vm changes during cell cycle and the impli-
cations of different types of ion channels in the cell cycle stages,
cancer cell migration and the differentiation of cancer stem cells.
That a wide variety of ion channel types affect the main hallmarks
of cancer is also suggested by Crottès et al. (2013), who focus on
the role of the sigma-1 receptor (Sig1R) in cancer cells. Sig1R
is a stress-activated chaperone associated with both the plasma
membrane and the interface between the mitochondria and the
endoplasmic reticulum. Sig1R is often expressed in tumors and
several lines of evidence suggest that it is implicated in regulating
Ca2+ homeostasis as well as some of the major types of ion chan-
nels. The authors suggest that Sig1R contributes to regulate the
ion channel expression and function in cancer cells in response to
environmental signals.
Following the lead of the seminal studies in lymphocytes
(DeCoursey et al., 1984) and early embryos (Day et al., 1993), K+
channels continue to have the lion’s share in the field. An overview
of the general role exerted by K+ channels in cell cycle progression
is provided by Ouadid-Ahidouch and Ahidouch (2013), whereas
the specific contribution of the voltage-gated KV1.3 and KV1.5
channels in human cancer is reviewed by Comes et al. (2013).
A group of voltage-gated K+ channels frequently found to be
involved in cancerogenesis comprises the ether-à-go-go (KV10 or
Eag; Pardo and Stühmer, 2008) and ether-à-go-go-related (KV11
or Erg; Arcangeli, 2005) subtypes, whose cell biology is under
intense investigation. In this issue, Herrmann et al. (2013) show
that the surface expression of the oncogenic KV10.1 channel
is regulated by the Golgi-resident protein PIST (also known as
GOPC), by an interaction mediated by PDZ domain.
In addition, growing evidence points to the role of ligand-
gated channels in cancer cells. In particular, the nicotinic acetyl-
choline receptors (nAChRs) are homo- or heteropentamers of
α and β subunits. These were originally identified in the ner-
vous system, but are now increasingly recognized to be widely
expressed outside the nervous system (Egleton et al., 2008;
Schuller, 2009; Ambrosi and Becchetti, 2013). Thus, Improgo
et al. (2013) discuss the role of the nAChR genes in lung can-
cer and propose an interesting mechanism whereby signaling
mediated by α3/α5/β4-containing nAChRs (which genome-wide
analyses correlate with increased smoking dependence and risk
of developing lung tumors) promote carcinogenesis in small cell
lung carcinoma cells.
Another central aspect of the function of normal and neoplas-
tic cells is the regulation of cell volume, as reviewed by Pedersen
et al. (2013). This applies especially to the secretive and absorbing
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epithelia, in which the massive transport of ions, organic com-
pounds, and fluid must be tightly matched to the control of cell
volume. Such regulatory processes are generally disrupted in can-
cer cells and the general oncologic relevance of these observations
turns on the fact that most cancers derive from epithelial cells.
The authors give a thorough overview of the interaction between
the tumor microenvironment and the altered regulation of ion
transport. Moreover, they discuss the role of cell volume in cell
proliferation and apoptosis, and the involvement of ion transport
in tumor drug resistance, with special focus on the implication of
chloride, calcium, and pH regulation.
A key step of the neoplastic progression is the regulation of
cell migration, whose derangement is implicated in the metastatic
cascade (Becchetti and Arcangeli, 2010) and tumor vasculariza-
tion (Fiorio Pla et al., 2012). Some subtypes of the Transient
Receptor Potential (TRP) channels have been found to participate
to the regulation of cell migration, as is reviewed by Fiorio Pla
and Gkika (2013). The authors especially focus on the implication
of TRP channels in cell migration during the neoplastic progres-
sion. A different and novel aspect of the regulation of cancer cell
migration is the implication of the tumor-associated carbonic
anhydrase IX (CA IX) on focal contacts during cell spreading and
migration. CA IX provides intracellular bicarbonate and extracel-
lular H+ to support cancer cell survival and invasiveness and is the
only human CA isoform containing an extracellular proteogly-
can domain (Monti et al., 2012). In their paper, Csaderova et al.
(2013) show the regulatory interaction of CA IX with the focal
contact sites, and provide the first evidence that CA IX localizes
in the focal adhesion structures.
Several of the above papers describe the potential therapeu-
tic applications of targeting specific ion channels and trans-
porters. Cancer treatment is however more specifically addressed
by Huber et al. (2013), who illustrate the use of ionizing radia-
tion. This causes double-strand DNA breakages and thus cancer
cell death, but also targets the plasma membrane. The ensuing
modifications of ion channels and transporters can contribute to
the survival of the irradiated cells. The authors discuss what is
known about the mechanisms of the radioresistance dependent
on ion transporters and suggest possible ways to make tumor cells
more sensitive to radiation by proper targeting of ion channels
and transporters.
Besides illustrating some of the hot topics in the field, the
papers of the present Research Topic Issue constitute a most use-
ful introduction to a literature that has already become too vast to
be mastered by a single investigator.
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